Medical images are used to make decisions on patient care and treatment but are limited to what the human eye can see. The extra information provided by TexRAD has the potential to assist clinicians to make more informed decisions, for example by predicting the prognosis and enabling the stratification of patients with cancer, so they receive the most appropriate treatment.
TexRAD has already proven its value in medical research and it is being applied in a wide range of studies which are then published in scientific journals. Projects developed with CCI are a good example of how research findings (also conducted at Future Processing) can be applied in the industry.
We have a very close relationship with Future Processing. Some of the key programmers actually also have an academic experience and help us with our algorithm development. So really it’s an extension of our team, more than just contracting our software development, sending out an idea and getting the code back.
Cambridge Computed Imaging Ltd (CCI) is part of Feedback PLC, a UK company listed on the AIM section of the London Stock Exchange. Feedback’s primary aim is to develop innovative techniques and improve workflow for medical practitioners involved in research and in treating patients.